PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer

AIMS: Prostate cancer is one of the most common malignancies in men. Biochemical recurrence (BCR) and progression following curative treatment pose a significant public health challenge. Thus, it is essential to explore effective biomarkers for disease progression monitoring and risk stratification....

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qi, Xie, Mixue, He, Mengye, Yan, Feifei, Chen, Ming, Xu, Suzhen, Zhang, Xiaochen, Shen, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344153/
https://www.ncbi.nlm.nih.gov/pubmed/30608394
http://dx.doi.org/10.1097/MD.0000000000013820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344153/
https://www.ncbi.nlm.nih.gov/pubmed/30608394
http://dx.doi.org/10.1097/MD.0000000000013820

Ejemplares similares